Heart failure drug less effective in real world; aldosterone antagonists

Contact: Sarah Avery sarah.avery@duke.edu 919-660-1306 Duke University Medical Center DURHAM, N.C. – A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice, according to researchers at Duke Medicine. Those differences have…

Related Keywords

United States ,American ,Laurag Qualls ,Bradleyg Hammill ,Paula Heidenreich ,Sarah Avery ,Stephenc Hammill ,Adrianf Hernandez ,Fredericka Masoudi ,Xiaojuan Mi ,Ericd Peterson ,Lesleyh Curtis ,Greggc Fonarow ,Duke University Medical Center ,Us Department Of Health ,Journal Of The American Medical Association ,Human Services ,Duke Clinical Research Institute ,American Heart Association ,Agency For Healthcare Research ,University Medical ,American Medical Association ,Duke Clinical Research ,Healthcare Research ,Developing Evidence ,Inform Decisions ,Ineffective Treatments ,Unintended Side Effects ,